India's Richest People 2026 edition · Source: Hurun India
Rank#1,233- Wealth
- ₹1,900 Cr
- Company
- Senores Pharmaceuticals
Current companies 13 active board seats
Past companies 4 historical roles
Total affiliations 17 Since Jun 2012
Shareholding value •••• Premium profile
About Swapnil Jatinbhai Shah
Data last updated:
Swapnil Jatinbhai Shah is a Director at Remus Pharmaceuticals Limited (since 2015), Managing Director at Senores Pharmaceuticals Limited (since 2021) and Director at Ratnatris Pharmaceuticals Private Limited (since 2021), and holds 10 more current directorships. The companies operate in Trading, Pharma and Business Outsourcing. The 10 current companies with reported revenue have a combined latest revenue of ₹1,220 Cr; the largest is Remus Pharmaceuticals Limited at ₹625 Cr (FY 2025). Earlier, Swapnil Jatinbhai Shah was a Director at Healthy Life Nutraceuticals Private Limited (2012–2014) and Director at Espee Lifesciences Private Limited (2013–2020) and 2 more.
Swapnil Jatin Shah is #1,233 among India's richest people (2026), with wealth of ₹1,900 Cr.
DIN 05259821
Primary Designation Director
Industry Trading
First Appointment 21 Jun 2012
Oldest Company Age 20 yrs
Largest company Remus Pharmaceuticals Limited · ₹625 Cr (FY 2025)
Combined revenue ₹1,220 Cr across 10 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Remus Pharmaceuticals Limited L24232GJ2015PLC084536 | Director | 21 Sep 2015 | 2015 | ₹625 Cr (FY 2025) | Active |
 Senores Pharmaceuticals Limited L24290GJ2017PLC100263 | Managing Director | 15 Oct 2021 | 2017 | ₹418 Cr (FY 2025) | Active |
 Ratnatris Pharmaceuticals Private Limited U24230GJ2005PTC047394 | Director | 15 Jan 2021 | 2005 | ₹142 Cr (FY 2025) | Active |
 Apnar Pharma Private Limited U73100GJ2014PTC081520 | Additional Director | 16 Jan 2026 | 2014 | ₹14.22 Cr (FY 2025) | Active |
 Espee Therapeutics Llp AAH-8938 | Designated Partner | 25 Nov 2016 | 2016 | ₹13.65 Cr (FY 2021) | Active |
| Renosen Pharmaceuticals Private Limited U51909GJ2019PTC108258 | Director | 22 May 2019 | 2019 | ₹7.36 Cr (FY 2025) | Active |
| Aelius Projects Llp AAP-1775 | Designated Partner | 03 May 2019 | 2019 | ₹45 Lakh (FY 2022) | Active |
| Everlane Properties Llp ACD-4863 | Partner | 14 Mar 2024 | 2023 | ₹4.5 Lakh (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Healthy Life Nutraceuticals Private Limited U15400GJ2012PTC070843 | Director | 21 Jun 2012 | 2012 | Converted To Llp | |
 Espee Lifesciences Private Limited U24100GJ2009PTC058169 | Director | 24 Jun 2013 | 2009 | ₹8.00 Cr (FY 2025) | Active |
| Sumer Enterprises Llp AAN-1429 | Designated Partner | 13 Aug 2018 | 2018 | Strike Off | |
| Ratnagene Lifescience Private Limited U24231GJ2021PTC125613 | Director | 15 Sep 2021 | 2021 | ₹1.98 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Swapnil Jatinbhai Shah
Directorship timeline
Open interactive timeline →Calypso Hospitality Llp
Espee Therapeutics Llp
Aelius Projects Llp
Sumer Enterprises Llp
Premium access
Shareholding and investment profile for Swapnil Jatinbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swapnil Jatinbhai Shah
Swapnil Jatinbhai Shah currently holds 13 directorships: Remus Pharmaceuticals Limited (Director, since 21 Sep 2015, revenue ₹625 Cr (FY 2025)); Senores Pharmaceuticals Limited (Managing Director, since 15 Oct 2021, revenue ₹418 Cr (FY 2025)); Ratnatris Pharmaceuticals Private Limited (Director, since 15 Jan 2021, revenue ₹142 Cr (FY 2025)); Apnar Pharma Private Limited (Additional Director, since 16 Jan 2026, revenue ₹14.22 Cr (FY 2025)); Espee Therapeutics Llp (Designated Partner, since 25 Nov 2016, revenue ₹13.65 Cr (FY 2021)); and 8 more.
Swapnil Jatinbhai Shah was first appointed on 21 Jun 2012 as Director at Healthy Life Nutraceuticals Private Limited. The most recent appointment on record is 16 Jan 2026 at Apnar Pharma Private Limited.
The 10 current companies of Swapnil Jatinbhai Shah that report revenue have a combined latest revenue of ₹1,220 Cr: Remus Pharmaceuticals Limited ₹625 Cr (FY 2025); Senores Pharmaceuticals Limited ₹418 Cr (FY 2025); Ratnatris Pharmaceuticals Private Limited ₹142 Cr (FY 2025); Apnar Pharma Private Limited ₹14.22 Cr (FY 2025); Espee Therapeutics Llp ₹13.65 Cr (FY 2021); and 5 more.
Swapnil Jatinbhai Shah held 4 earlier board appointments: Healthy Life Nutraceuticals Private Limited (Director, 21 Jun 2012 to 17 Jul 2014); Espee Lifesciences Private Limited (Director, 24 Jun 2013 to 17 Mar 2020); Sumer Enterprises Llp (Designated Partner, from 13 Aug 2018); Ratnagene Lifescience Private Limited (Director, from 15 Sep 2021).
The current boards of Swapnil Jatinbhai Shah's companies include Anar Swapnil Shah (Remus Pharmaceuticals Limited), Arpit Deepakkumar Shah (Remus Pharmaceuticals Limited), Ashutosh Naginbhai Valani (Remus Pharmaceuticals Limited), Balwant Purohit (Remus Pharmaceuticals Limited), Bhavik Rashmikant Shah (Remus Pharmaceuticals Limited), Deval Bakulkumar Patel (Remus Pharmaceuticals Limited), among others.